Back to Search Start Over

Donepezil for negative signs in elderly patients with schizophrenia: an add-on, double-blind,crossover,placebo-controlled study.

Authors :
Mazeh, D.
Zemishlani, H.
Barak, Y.
Mirecki, I.
Paleacu, D.
Source :
International Psychogeriatrics; Sep2006, Vol. 18 Issue 3, p429-436, 8p, 1 Chart, 1 Graph
Publication Year :
2006

Abstract

The article presents a double-blind, crossover, placebo-controlled study on the use of donepezil for negative signs in elderly patients with schizophrenia. Donepezil inhibits cholinesterase, thus enhancing cholinergic neurotransmission. The efficacy of donepezil was in elderly patients with chronic schizophrenia and severe cognitive impairment.

Details

Language :
English
ISSN :
10416102
Volume :
18
Issue :
3
Database :
Complementary Index
Journal :
International Psychogeriatrics
Publication Type :
Academic Journal
Accession number :
22507171
Full Text :
https://doi.org/10.1017/S1041610205003017